| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GBIO | Common Stock | Options Exercise | $8,100 | +3,347 | +28% | $2.42 | 15,169 | 15 Oct 2024 | Direct | |
| transaction | GBIO | Common Stock | Tax liability | -983 | -6.5% | 14,186 | 15 Oct 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GBIO | Restricted Stock Units | Options Exercise | $0 | -3,347 | -9.1% | $0.000000 | 33,468 | 15 Oct 2024 | Common Stock | 3,347 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the right to receive one share of the company's common stock. |
| F2 | The grant of 53,550 restricted stock units was made on April 5, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on April 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. |